Class I Drug Recall D-0388-2026 by ANTHONY TRINH

drug-class-i

Filed March 13th, 2026

Detected March 27th, 2026

Summary

The FDA has initiated a Class I drug recall (D-0388-2026) for SILINTAN 25 pills, voluntarily initiated by ANTHONY TRINH, 123Herbals LLC. The recall is due to the presence of undeclared meloxicam, a potentially dangerous ingredient.

View original document View source feed page

What changed

The Food and Drug Administration (FDA) has announced a Class I recall for SILINTAN 25 pills, identified by recall number D-0388-2026. The recall was initiated voluntarily by ANTHONY TRINH, 123Herbals LLC, due to the product being marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). FDA analysis revealed the presence of undeclared meloxicam, a significant safety concern.

This recall impacts nationwide distribution within the USA. Consumers who have purchased SILINTAN 25 pills should immediately stop using the product and consult with a healthcare professional. Drug manufacturers and distributors should review their product lines for undeclared ingredients and ensure compliance with NDA/ANDA requirements. The recall is ongoing, and further information can be found via the FDA's enforcement database.

What to do next

Consumers should stop using SILINTAN 25 pills and consult a healthcare professional.
Manufacturers should review product formulations for undeclared ingredients.
Ensure compliance with NDA/ANDA requirements for all marketed drugs.

Source document (simplified)

json { "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-03-18", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "status": "Ongoing", "city": "Rosemead", "state": "CA", "country": "United States", "classification": "Class I", "openfda": { }, "product_type": "Drugs", "event_id": "98258", "recalling_firm": "ANTHONY TRINH, 123Herbals LLC", "address_1": "7214 Berne St", "address_2": "N/A", "postal_code": "91770-3844", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA nationwide", "recall_number": "D-0388-2026", "product_description": "SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China", "product_quantity": "N/A", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.", "recall_initiation_date": "20251020", "center_classification_date": "20260313", "report_date": "20260311", "code_info": "All lots within expiry" } ] }